Nuclear Medicine
CLINICAL DECISION SUPPORT
| Clinical Evaluation |
|---|
| Amino acid uptake |
| Type of Imaging |
| PET |
| Grade of Recommendation |
| A (strongly recommended) |
| Level of Evidence |
| well-established clinical and Nuclear Medicine recommendations |
| Effective Dose |
| 25.0 µSv/MBq |
| Bibliographic Reference |
|
Law, I., Albert, N.L., Arbizu, J. Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolab... read moreLaw, I., Albert, N.L., Arbizu, J. Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabeled amino acids and [18F]FDG: version 1.0. Eur J Nucl Med Mol Imaging. 2019; https://doi.org/10.1007/s00259-018-4207-9
Albert NL, Galldiks N, Ellingson BM, van den Bent MJ, Chang SM, Cicone F, de Groot J, Koh ES, Law I, Le Rhun E, Mair MJ, Minniti G, Rudà R, Scott AM, Short SC, Smits M, Suchorska B, Tolboom N, Traub-Weidinger T, Tonn JC, Verger A, Weller M, Wen PY, Preusser M. PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group, Lancet Oncol. 2024,https://doi.org/10.1016/S1470-2045(23)00525-9 read less |
| Guide to Nuclear Medicine |
| Read the corresponding chapter |